-
What is MAH policy in China?
ChatGPT/PharmaSources
November 09, 2023
In China, the Marketing Authorization Holder (MAH) system refers to a policy shift in the regulation of pharmaceutical products.
-
Suggesting on the best practice of becoming MAH of a drug in China
ChatGTP/PharmaSources
November 09, 2023
Becoming a Marketing Authorization Holder (MAH) for a drug in China involves navigating a complex regulatory landscape.
-
How to register a drug into the market in China?
ChatGPT/PharmaSources
November 08, 2023
Registering a drug for market approval in China involves a comprehensive and multi-step process that requires adherence to the country's regulatory requirements.
-
What are the new developments of the CNS drug R&D?
ChatGPT/PharmaSources
November 08, 2023
The research and development of Central Nervous System (CNS) drugs have been the focus of ongoing advancements and innovations.
-
What is CNS disease?
ChatGPT/PharmaSources
November 08, 2023
Central Nervous System (CNS) disease refers to a broad category of medical conditions that affect the brain and spinal cord, which together comprise the central nervous system.
-
A comprehensive review of the currently marketed ADC drugs: the industry maintains high prosperity
WND
November 07, 2023
Antibody-drug conjugates (ADCs) are a class of drugs composed of antibodies targeting tumor antigens and a variable number of small molecule toxins linked through connectors.
-
Development Progress of Bispecific Antibodies in China
Yefenghong/PharmaSources
November 07, 2023
Approved Bispecific Antibody Products Worldwide, New progress in the field of bispecific antibodies.
-
Research Progress on Platelet Membrane Biomimetic Drug Delivery Systems
Xiaomichong/PharmaSources
November 02, 2023
Currently, in the research of nanoscale drug delivery systems, there are several problems such as poor biocompatibility, short blood circulation lifespan, insufficient active targeting, and low permeability through biological membranes.
-
Research Progress on the Application of Biologics in Childhood Asthma.
Xiaomichong
October 30, 2023
Asthma is a heterogeneous, complex chronic disease. Children with severe asthma often experience acute exacerbations, leading to impaired lung function and poor quality of life.
-
MNC ramps up AI pharmaceutical layout, can AI and pharmaceuticals collide to spark "fireworks"?
Yefenghong/PharmaSources
October 27, 2023
AI (Artificial Intelligence) pharmaceuticals refer to the use of artificial intelligence technologies such as big data, cloud computing, and deep learning to assist in drug discovery, drug management, efficacy analysis, and other processes.